Oct 16, 2025 06:05AM

Oct 1, 2025 07:30AM

Sep 17, 2025 07:32AM

Sep 10, 2025 03:07PM

May 5, 2025 08:00AM

Apr 15, 2025 08:01AM

Apr 10, 2025 08:37AM Biocon Biologics Announces U.S. FDA Approval for Jobevne™, Biosimilar Bevacizumab, Expanding Its Oncology Portfolio

Mar 7, 2025 08:01AM

Mar 6, 2025 07:00AM

Feb 24, 2025 07:00AM

Sep 25, 2024 01:05AM

Aug 29, 2024 01:13AM

May 21, 2024 08:00AM

Feb 29, 2024 09:56AM Biocon Biologics Secures US Market Entry Date for Bmab 1200, a Proposed Biosimilar to Stelara®

Jul 3, 2023 12:40PM

Jun 15, 2022 04:01PM

Jun 9, 2022 07:00AM

Jun 7, 2022 04:00PM

Jul 28, 2021 11:29PM

Aug 31, 2020 06:00AM

Jul 21, 2020 02:00AM Biocon Biologics and Voluntis Join Hands for Global Collaboration on Digital Therapeutics for Insulins

Jun 11, 2020 06:35PM

Mar 27, 2020 03:00PM

Mar 9, 2020 08:05AM

Mar 9, 2020 08:00AM

Feb 26, 2020 05:00AM

Dec 2, 2019 07:00AM

Oct 15, 2019 07:45AM Sun Ophthalmics to Present Updated CEQUA™ and XELPROS™ Data at AAOPT/WCO 2019

Oct 19, 2018 09:31AM

Oct 19, 2018 09:30AM

Sep 21, 2018 09:30AM

Jun 4, 2018 04:52PM

Jun 1, 2018 05:18PM

Dec 29, 2017 01:30AM

Dec 1, 2017 11:33AM Mylan (MYL) and Biocon Announce FDA Approval for Ogivri to Treat HER2-Positive Breast and Gastric Cancers

Dec 1, 2017 11:31AM

Nov 30, 2017 12:55PM

Jul 13, 2017 05:05PM

Jul 13, 2017 05:02PM

Feb 16, 2017 08:13AM

Feb 16, 2017 08:08AM

Jan 11, 2017 08:01AM Mylan (MYL), Biocon Announce FDA Acceptance of Biosimilar Trastuzumab BLA

Jan 11, 2017 08:00AM

Dec 27, 2016 08:06AM

Dec 27, 2016 08:00AM

322,245 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All